FDA UNTITLED_LETTER - QuVa Pharma, Inc. - September 24, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore QuVa Pharma, Inc.

Record Details

This UNTITLED LETTER record concerns QuVa Pharma, Inc., with an inspection on September 24, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: QuVa Pharma, Inc.
Inspection Date: September 24, 2024
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Frances G. Bormel (Director)

Open in Dashboard

ID · 9807dbff-8897-48ee-bc96-bc877d478daf

Violation Codes9

21 U.S.C. 353b21 U.S.C. 360eee-121 U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 331(k)21 U.S.C. 351(a)(2)(B)21 U.S.C. 331(a)21 U.S.C. 351(a)(2)(A)21 CFR 211.192

Full citation text and observation details available on the Dashboard.